E
Telomir Pharmaceuticals, Inc. TELO
$4.58 -$0.45-8.95%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -16.53M -22.96M -18.74M -18.84M -13.07M
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges 4.34M 5.08M 5.83M 5.95M 1.61M
Total Other Non-Cash Items 7.00M 12.28M 7.49M 7.49M 7.49M
Change in Net Operating Assets 126.40K 48.90K -1.12M 343.30K 113.90K
Cash from Operations -5.07M -5.55M -6.55M -5.06M -3.86M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued 0.00 1.07M 2.76M 3.12M 3.12M
Total Debt Repaid -534.90K -404.90K -101.00K -101.00K 0.00
Issuance of Common Stock 6.87M 5.92M 5.92M 5.92M 1.09M
Repurchase of Common Stock -- -- -- -90.00K -90.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 0.00 -200.40K -160.10K -511.60K -256.00K
Cash from Financing 6.34M 6.38M 8.42M 8.34M 3.86M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1.26M 832.20K 1.87M 3.27M -200.00
Weiss Ratings